best electrolyte brands for glp-1 side effects 5 Expert-Recommended Electrolytes Users proven ingredients Long-Term Effects Of GLP-1 Medications:
Description
The evidence base for GLP-1 receptor agonists in fatty liver disease has expanded considerably in recent years

The total body weight, bone mineral density (BMD), and bone turnover markers (BTMs) [C-terminal telopeptide of type 1 collagen (CTX) and procollagen type I N-propeptide (P1NP)] were measured at baseline and 20 weeks

Only one study, which evaluated 21 PWS children, reported a case of mild positivity for anti-thyroid peroxidase antibodies ( Regarding hyperthyroidism, a single case with an unclear origin treated with thiamazole was reported in a group of adult patients with PWS ( Based on the data available in the literature, there does not appear to be a clear correlation between genotype and thyroid dysfunction in individuals with PWS

Instead, let's lay out some evidence, and let you be the judge

Although effective with supervised dosing, it is no longer first-line therapy due to poor adherence, variable efficacy, and hepatotoxicity concerns (168, 296)

To induce weight loss, we employed the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide and the neuropeptide Y receptor Y2 (NPY2R) agonist BI8271, which potentiates GLP-1R-mediated weight loss
